• No results found

Personalized medicine in advanced urothelial cancer: when to treat, how to treat and who to treat

N/A
N/A
Protected

Academic year: 2020

Share "Personalized medicine in advanced urothelial cancer: when to treat, how to treat and who to treat"

Copied!
5
0
0

Loading.... (view fulltext now)

Full text

Loading

Figure

Fig. 1. Pathways to Personalized Canceridentify active targets for drug discovery andtissues, to screen for novel markers and toidentify biomarkers expressed in differenttion and offer systematic approaches toability of standard clinicopathologic informa-p

References

Related documents

Smedley, “Review of voltage compensation methods in dynamic voltage restorer (DVR),” in Proc.IEEE Power Energy Soc. Martinez and J.M Arnedo, “Voltage sag studies in

To predict accident severity by using different data mining techniques that are classification and regression trees, random forest, ID3, functional tree, naïve

Objective: To assess the quality of life (QoL) and recurrence of disease in patients with eosinophilic (ECRSwNP) and non-eosinophilic chronic rhinosinusitis with nasal

From this analysis we will find out the financial performance and this analysis from the annual report (Income statements and Balance sheets) provided by Canara

There was no statistically significant correlation detected between low levels of protein C, protein S and antithrombin with maternal characteristic (age and

The Malaysian Clinical Practice Guideline (CPG) on the Management of Breast Cancer recommends the following: mammography screening may be performed biennially

Different reception apparatus channel coding for orthogonal recurrence division multiplexing (OFDM) transmission over dispersive channels is reexamined in light of the

The objectives of this study were to determine the prevalence of self-reported depression, anxiety and stress among RA patients attending the Rheumatology Clinic in